NCT06874725View on ClinicalTrials.gov

Latent Tuberculosis in Type 2 Diabetes

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

April 18, 2018

Primary Completion Date

April 30, 2024

Study Completion Date

April 18, 2025

Conditions
Latent Tuberculosis Infection
Interventions
DRUG

Rifapentine and Isoniazid for 3 months

tuberculosis preventive therapy (TPT) with 3 months of weekly rifapentine plus isoniazid (3HP)

DRUG

Isoniazid (INH) daily for 9 months

tuberculosis preventive therapy (TPT) with 9 months of daily isoniazid (9H)

Trial Locations (1)

407219

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER